Bortezomib and/or Daratumumab for Treatment of Refractory Autoimmune Hemolytic Anemia

被引：0
|
作者：
McGlothlin, John [1 ]
Abeykoon, Jithma P. [2 ]
Al-Hattab, Eyad [2 ]
Ashrani, Aneel A. [2 ]
Elliott, Michelle A. [2 ]
Go, Ronald [2 ]
Hook, C. Christopher [2 ]
Pardanani, Animesh [2 ]
Pruthi, Rajiv K. [2 ]
Sridharan, Meera [2 ]
Wolanskyj, Alexandra P. [2 ]
机构：
[1] Mayo Clin, Dept Internal Med, Rochester, MN USA
[2] Mayo Clin, Div Hematol, Rochester, MN USA
来源：
BLOOD | 2022年 / 140卷
关键词：
D O I：
10.1182/blood-2022-159270
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：5328 / 5330
页数：3
相关论文
共 50 条
  • [1] Bortezomib and daratumumab in refractory autoimmune hemolytic anemia
    McGlothlin, John
    Abeykoon, Jithma
    Al-Hattab, Eyad
    Ashrani, Aneel A.
    Elliott, Michelle
    Hook, C. Christopher
    Pardanani, Animesh
    Pruthi, Rajiv
    Sridharan, Meera
    Wolanskyj, Alexandra
    Rouse, Rachelle
    Go, Ronald
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (10) : E263 - E265
  • [2] Daratumumab for refractory warm autoimmune hemolytic anemia
    Jain, Ankur
    Gupta, D. K.
    ANNALS OF HEMATOLOGY, 2021, 100 (05) : 1351 - 1353
  • [3] Daratumumab for refractory warm autoimmune hemolytic anemia
    Ankur Jain
    D. K. Gupta
    Annals of Hematology, 2021, 100 : 1351 - 1353
  • [4] Daratumumab for Posttransplant Autoimmune Hemolytic Anemia
    Abduallah, Yaqeen
    Kennah, Michael
    Prince, Connor
    Masurekar, Ashish
    Kekre, Natasha
    Nampoothiri, Ram Vasudevan
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2025,
  • [5] Daratumumab monotherapy in refractory warm autoimmune hemolytic anemia and cold agglutinin disease
    Jalink, Marit
    Jacobs, Chaja F.
    Khwaja, Jahanzaib
    Evers, Dorothea
    Bruggeman, Coty
    Fattizzo, Bruno
    Michel, Marc
    Crickx, Etienne
    Hill, Quentin A.
    Jaeger, Ulrich
    Kater, Arnon P.
    Makelburg, Anja B. U.
    Breedijk, Anouk
    te Boekhorst, Peter A. W.
    Hoeks, Marlijn P. A.
    de Haas, Masja
    D'Sa, Shirley
    Vos, Josephine M. I.
    BLOOD ADVANCES, 2024, 8 (11) : 2622 - 2634
  • [6] DARATUMUMAB FOR THE TREATMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA IN PEDIATRIC PATIENTS POST-HEMATOPOIETIC CELL TRANSPLANT
    Yoo, Justin
    Obordo, Jeremy
    Schoettler, Michelle
    Qayed, Muna
    Hughes, Kaley
    Harris, Anora
    Spencer, Katie
    Parikh, Suhag
    Chandrakasan, Shanmuganathan
    Chonat, Satheesh
    Williams, Kirsten M.
    PEDIATRIC BLOOD & CANCER, 2023, 70 : S214 - S215
  • [7] Bortezomib in autoimmune hemolytic anemia and beyond
    Pasquale, Raffaella
    Giannotta, Juri Alessandro
    Barcellini, Wilma
    Fattizzo, Bruno
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2021, 12
  • [8] RITUXIMAB TREATMENT OF REFRACTORY AUTOIMMUNE HEMOLYTIC ANEMIA AND REFRACTORY AUTOIMMUNE THROMBOCYTOPENIC PURPURA
    Raptis, S.
    Mantzourani, M.
    Dimitrakopoulou, L.
    Vassilakopoulos, T.
    Tsirkinidis, P.
    Pangalis, G.
    Vaiopoulos, G.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 497 - 497
  • [9] Bortezomib for the Management of Relapsed or Refractory Warm Autoimmune Hemolytic Anemia: A Scoping Review
    Johnson, Eric
    Lesh, Nicholas
    Hildebrand, Gregory
    Shah, Harsh
    Osman, Afaf
    Abou-Ismail, Mouhamed Yazan
    BLOOD, 2021, 138
  • [10] Successful treatment with daratumumab for post-HSCT refractory hemolytic anemia
    Even-Or, Ehud
    Eddin, Adeeb Naser
    Shadur, Bella
    Schejter, Yael Dinur
    Najajreh, Mohammad
    Zelig, Orly
    Zaidman, Irina
    Stepensky, Polina
    PEDIATRIC BLOOD & CANCER, 2020, 67 (01)
12345